Healthcare Triangle Inc has a consensus price target of $2 based on the ratings of 1 analysts. The high is $2 issued by EF Hutton on September 28, 2022. The low is $2 issued by EF Hutton on September 28, 2022. The 2 most-recent analyst ratings were released by EF Hutton on September 28, 2022 and March 14, 2022, respectively. With an average price target of $3 between EF Hutton, there's an implied 172.73% upside for Healthcare Triangle Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Healthcare Triangle (NASDAQ:HCTI) was reported by EF Hutton on September 28, 2022. The analyst firm set a price target for $2.00 expecting HCTI to rise to within 12 months (a possible 81.82% upside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for Healthcare Triangle (NASDAQ:HCTI) was provided by EF Hutton, and Healthcare Triangle maintained their buy rating.
There is no last upgrade for Healthcare Triangle
There is no last downgrade for Healthcare Triangle.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Triangle, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Triangle was filed on September 28, 2022 so you should expect the next rating to be made available sometime around September 28, 2023.
While ratings are subjective and will change, the latest Healthcare Triangle (HCTI) rating was a maintained with a price target of $4.00 to $2.00. The current price Healthcare Triangle (HCTI) is trading at is $1.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.